Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

EBR Systems (ASX:EBR) gained FDA approval for WiSE in April 2025 and it is the world’s only wireless endocardial (placed ...

Haemonetics has acquired Vivasure, an Ireland-based company developing next-generation technology for percutaneous vessel ...

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510–511 Million Meets or Exceeds Prior GuidancePreviously Provided FY 2025 Adjusted ...

Progyny’s presentation at the JP Morgan Healthcare Conference begins at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time on Tuesday, January 13, 2026. Mr. Anevski will be joined by Mark Livingston, ...

INTERNATIONAL Medical Assist Network (IMAN) is a global telehealth initiative designed to bridge the gap between underserved populations everywhere in the world ...

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

PuroClean, one of the country's leading property restoration and remediation franchises, is proud to announce a National ...

Strategic Fit Assessment Finds Leadership Concentrated in Enterprise-Scale Clinical Performance and Resilience While Cloud Agility, Partnership Value, and Patient Engagement Create New "Wedge" ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, and Eisai Co., Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a ...

Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi and Canalevia-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1 ...

The Center for Healthcare Quality & Payment Reform, a national policy organization, found 68 rural Kansas hospitals are at ...